Breaking News
Top News
-
Morningstar Says Software Stocks Haven’t Been This Undervalued In 3 Years. These 3 Look Like Good Deals.
-
Capricorn Fund Makes a Huge Bet on Nerve Repair With 687,000 Share Axogen (AXGN) Investment Worth $22.4 Million
-
Five Big Tech Earnings Could Decide Bitcoin’s Next Move This Week
-
Getty Realty Stockholders Re-Elect Directors, Back Say-on-Pay as CEO Touts 2025 Growth
-
3 Impressive Quantum Computing Stocks to Buy Now
-
McDonald’s unveils “Stranger Things” Happy Meal in major collab
-
Virgin Galactic Holdings (SPCE) Planning for Flight-Testing Program and Space Flights
-
Recursion Pharmaceuticals (RXRX) Offers Encouraging Prospects After Setting 2026 Priorities
-
ThredUp Inc. (TDUP) Garnering Attention with Mass-Market Resale Network Positioning
-
Here is Why Altimmune Inc. (ALT) Appears to be an Attractive Penny Stock
-
Ennis Inc. (EBF) Delivers In-Line Fourth Quarter Results
-
Here is Why Investors Should Pay Attention to IRADIMED Corp. (IRMD)
-
BofA Reaffirms Buy Rating for Agios Pharmaceuticals (AGIO)
-
Insteel Industries (IIIN) Sits Comfortably With Current Market Position, Following Q2 Announcement
-
Mama’s Creations (MAMA) Fuels Confidence Following Q4 Outperformance
-
Why Does Burford Capital (BUR) Appear so Attractive
-
Northland Reaffirms Outperform Rating for MiMedx Group (MDXG)
-
What Makes Maze Therapeutics (MAZE) One of the Best Oversold Small-Cap Stocks to Buy
-
Investors Protecting Stocks at Record Eye Bets on Higher Rates
-
Raízen Adds Cash in Offer to Creditors, Balks at Board Changes
2026-02-05



































